| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.085 | 0.05 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |